ELMED Life Sciences Secures $2.7 Million in Series A Funding

ELMED Life Sciences, a growing biotech startup, has successfully raised $2.7 million (approximately Rs 25 crore) in a Series A funding round led by AgriSURE Fund, administered by NABVENTURES. The capital will support the expansion of manufacturing capabilities, bolster research and development, and enhance distribution in both domestic and international markets.

About ELMED Life Sciences

Founded by Pruthivin Reddy Madduri with co-founder Nikhil Konkathi, ELMED Life Sciences specializes in creating probiotic and biological solutions for various sectors, including animal health, agriculture, aquaculture, and human health. The company offers a range of products aimed at poultry, dairy, livestock, aquaculture, and soil health, with a strong emphasis on productivity and sustainability using microbiome-based solutions.

Plans for Expansion

ELMED intends to enhance its manufacturing operations in Hyderabad and broaden its distribution channels in tier 2 and tier 3 markets. Additionally, the company is focused on increasing its presence in international markets where the demand for sustainable and antibiotic-free solutions is on the rise.

Current Operations

The brand currently exports its products to over 18 countries and employs a B2B model tailored for enterprise clients across various sectors.